نتائج البحث - "Rasenack, J."

1

دورية

Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection

المؤلفون: Schories, M., Peters, T., Rasenack, J.

المصدر: Journal of Hepatology; 2000, Vol. 33 Issue: 5 p799-811, 13p

2

دورية

Interferon therapy in patients with chronic hepatitis C and schistosomiasis

المؤلفون: Kamal, S. M., Madwar, M. A., Peters, T., Fawzy, R., Rasenack, J.

المصدر: Journal of Hepatology; 2000, Vol. 32 Issue: 1 p172-173, 2p

3

دورية أكاديمية

[513] EFFICACY OF TELBIVUDINE VS LAMIVUDINE AT 2 YEARS IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B WHO ARE ELIGIBLE FOR TREATMENT BASED ON GUIDELINES

المؤلفون: Rasenack, J., Poynard, T., Lai, C.-L., Gane, E., Brown, N.A., Heathcote, J.

المصدر: Journal of Hepatology. Apr2007, Vol. 46, pS195-S195. 1p.

4

دورية أكاديمية

7 Natural history and outcome of acute hepatitis C in patients with end stage renal disease

المؤلفون: Kamal, S., Rasenack, J., Hafez, A., Brigel, B., Chen, J., Gamal, I., Shaker, H., Saad, N., Afdhal, N.

المصدر: Journal of Hepatology. Feb2006 Supplement 2, Vol. 44, pS5-S5. 1p.

5

دورية أكاديمية

Effects of aromatase inhibition by methylandrostendion in patients with cirrhosis of the liver

المؤلفون: Petersen, K.-G., Rasenack, J., Roessle, M.

المصدر: Journal of Hepatology. Apr2003 Supplement 2, Vol. 38, p67. 1p.

6

دورية

Evaluation of the safety and efficacy of once-weekly PEG/interferon alfa-2A (PEGASYS™) for chronic hepatitis C. A multinational, randomized study

المؤلفون: Zeuzem, S., Feinman, S.V., Rasenack, J., Heathcote, E.J., Lai, M.-Y., Gane, E., O'Grady, J., Reichen, J., Brunda, M.J.

المصدر: Journal of Hepatology; 2000, Vol. 32 Issue: 1 p29-29, 1p

7

دورية أكاديمية

1421 ALISPORIVIR (ALV) PLUS PEGINTERFERON/RIBAVIRIN (PR) ACHIEVES HIGH SVR12 RATES AMONG NULL RESPONDERS, IL28BCT/TT AND CIRRHOTIC HCVG1 PATIENTS (FUNDAMENTAL STUDY INTERIM ANALYSIS).

المؤلفون: Buti, M., Flisiak, R., Rasenack, J., Davis, G., Alberti, A., Goeser, T., Stanciu, C., Chuang, W.-L., Tabak, F., Kao, J.-H., Streinu-Cercel, A., Hofstetter, G., Wang, J., Avila, C., Orsenigo, R.

المصدر: Journal of Hepatology. Apr2013 Supplement 1, Vol. 58, pS572-S572. 1p.

8

دورية أكاديمية

P747 ASSOCIATION OF A GENETIC VARIANT OF THE MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN (MAVS) WITH INTERFERON RESPONSE IN CHRONIC HEPATITIS C VIRUS INFECTION.

المؤلفون: Fischer, J., Böhm, S., Deichsel, D., Knop, V., Klinker, H., Möller, B., Rasenack, J., Hinrichsen, H., Spengler, U., Buggisch, P., Sarrazin, C., Berg, T.

المصدر: Journal of Hepatology. Apr2014 Supplement, Vol. 60, pS320-S320. 1p.

مصطلحات موضوعية: *HUMAN genetic variation, *MITOCHONDRIAL proteins, *ANTIVIRAL agents, *CELLULAR signal transduction, *CHRONIC hepatitis C

9

دورية أكاديمية

745 eGFR IMPROVEMENT IN CHRONIC HEPATITIS B PATIENTS WITH TELBIVUDINE TREATMENT IS INDEPENDENT OF ANTIVIRAL ACTIVITY.

المؤلفون: Gane, E.J., Liaw, Y.F., Wang, Y., Lai, C.-L., Rasenack, J., Zeuzem, S., Chan, H.L.Y., Ren, H., Dong, Y., Uddin, A., Jung, M.E., Bosset, S., Trylesinski, A.

المصدر: Journal of Hepatology. Apr2013 Supplement 1, Vol. 58, pS302-S302. 1p.

10

دورية أكاديمية

9 ASSOCIATION OF A GENETIC VARIANT OF THE TOLL-LIKE RECEPTOR 9 (TLR9) WITH SPONTANEOUS VIRAL CLEARANCE AND WITH INTERFERON RESPONSE IN CHRONIC HEPATITIS C VIRUS INFECTION.

المؤلفون: Fischer, J., B, S., Deichsel, D., Knop, V., Klinker, H., M, B., Rasenack, J., Hinrichsen, H., Spengler, U., Buggisch, P., Sarrazin, C., Berg, T.

المصدر: Journal of Hepatology. Apr2013 Supplement 1, Vol. 58, pS4-S5. 0p.

تنقيح النتائج